Cancer Genome & Epigenetics

$56,413P30FY2024CANIH

Sanford Burnham Prebys Medical Discovery Institute, La Jolla CA

Investigators

Linked publications, trials & patents

Paper 39677772 Paper 39627191 Paper 39605455 Paper 39484541 Paper 39386552 Paper 39294158 Paper 39281885 Paper 39229183 Paper 39198884 Paper 39091799 Paper 38949950 Paper 38838144 Paper 38826238 Paper 38805583 Paper 38741205 Paper 38740554 Paper 38729306 Paper 38712107 Paper 38710674 Paper 38464189 Paper 38460130 Paper 38370825 Paper 38260668 Patent 9320810 Patent 9115170 Patent 8987213 Patent 8951971 Patent 8637635 Patent 8598316 Patent 8598112 Patent 8563248 Patent 8536132 Patent 8506965 Patent 8470780 Patent 8367621 Patent 8329859 Patent 8188501 Patent 8188220 Patent 8188051 Patent 8178104 Patent 8119404 Patent 8048983 Patent 8017326 Patent 7919466 Patent 7910370 Patent 7786347 Patent 7741521 Patent 7723474 Patent 7671021 Patent 7560242 Patent 7544767 Patent 7501486 Patent 7488792 Patent 7393653 Patent 7341710 Patent 7192921 Patent 6933281 Patent 6743892 Patent 6537553 Patent 6528481 Patent 6514761 Patent 6475488 Patent 6323335 Patent 6306365 Patent 6296832 Patent 6232287 Patent 6177542 Patent 6068829 Patent 5981478 Patent 5955572 Patent 5922676 Patent 5912234 Patent 5910451 Patent 5908750 Patent 5880267 Patent 5858360 Patent 5830504 Patent 5707853 Patent 5702897 Patent 5684134 Patent 5658778 Patent 5654267 Patent 5654145 Patent 5646248 Patent 5645248 Patent 5627263 Patent 5624832 Patent 5624799 Patent 5622699 Patent 5599918 Patent 5550019 Patent 5539094 Patent 5536814 Patent 5484710 Patent 5457048 Patent 5453492 Patent 5453489 Patent 5081227 Patent 5041380 Patent 4792525

Abstract

The overall goals of the Cancer Genome & Epigenetics (CGE) Program (formerly Tumor Initiation and Maintenance Program) are to identify the cells that give rise to tumors and the signals that allow these cells to expand uncontrollably, and to use this information to develop more effective approaches to treating human cancer.

View original record on NIH RePORTER →